Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2009
10/15/2009WO2009105278A3 Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells
10/15/2009WO2009062193A3 Methods for administering corticosteroid formulations
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033790A3 Use of a peptide as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2009033768A3 Use of a peptide as a therapeutic agent
10/15/2009US20090258946 Electrostatically charged nasal application multipurpose products and method
10/15/2009US20090258944 Method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewith, and their use
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258911 Composition and method for treating fibrotic diseases
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258882 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors
10/15/2009US20090258858 Muscarinic acetylcholine receptor antagonists
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258046 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090257993 Lactic Acid Producing Bacteria and Lung Function
10/15/2009DE102008015607A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2719440A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
10/15/2009CA2662636A1 N-acetylcysteine compositions and methods for treating acute exacerbations of inflammatory lung disease
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108366A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009CN101558042A Method of preparing montelukast and intermediates used therein
10/14/2009CN101557815A Compositions and methods for treating infectious bronchitis
10/14/2009CN101554455A Traditional Chinese medicine preparation for treating cold
10/14/2009CN101554446A Traditional Chinese medicine composition for treating chronic pharyngitis
10/14/2009CN101554425A Drug for curing chronic bronchitis
10/14/2009CN101554422A Application of tangerine peel extract in preparation of drugs for curing pulmonary fibrosis
10/14/2009CN101554407A Shuanghuanglian soluble powder preparation technique and application thereof
10/14/2009CN101554405A Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof
10/14/2009CN101554403A Medicament for treating rhinitis and preparation method thereof
10/14/2009CN101554383A Chinese traditional medicine composition for preventing and curing infectious laryngotracheitis of birds
10/14/2009CN101554380A Drug for preventing and curing H1N1 flu virus by adopting 4 (3H) quinazolone
10/14/2009CN101554230A Functional food for relieving chronic pharyngitis
10/14/2009CN100549010C Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations containing the same
10/14/2009CN100548996C 5-phenylthiazole derivatives and its use for preparing medicine
10/14/2009CN100548978C Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
10/14/2009CN100548372C Preparation of alpha-1 protein inhibitor
10/14/2009CN100548358C Antitussive agent
10/14/2009CN100548347C Medicine combination of tuber of dwarf lilyturf and asarone
10/14/2009CN100548328C Buccal tablet for mouth cavity and pharyngeal cavity inflammation based on mucus medicine
10/14/2009CN100548321C Application of extractive of Abarema elliptica in use for preparing antiallergic medication, food and cosmetic
10/14/2009CN100548314C Snake venom cytotoxin, preparation method and application thereof
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548286C A solid dispersion of ambroxol hydrochloride and composition thereof
10/14/2009CN100548135C Method for producing tea of loquat flower petals
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601726 Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitors
10/13/2009US7601723 For treating asthma and improving insulin sensitivity
10/13/2009US7601720 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2455298C Condensed polycyclic compounds
10/13/2009CA2322311C Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
10/08/2009WO2009123967A1 5,6,7,8-tetrahydroquinazolin-2-amine derivatives and related compounds as histamine h4 receptor modulators for the treatment of asthma
10/08/2009WO2009123316A1 Heterocyclic derivative and use thereof
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009123207A1 Oral rinse composition
10/08/2009WO2009122748A1 Therapeutic agent for respiratory diseases or allergic diseases
10/08/2009WO2009121631A2 Nanoparticles for targeted delivery of active agents to the lung
10/08/2009WO2009040045A3 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
10/08/2009WO2009033758A3 Use of the peptide phpfhffvyk as therapeutic agent
10/08/2009WO2007124849A3 Inhibitors of the task-1 and task-3 ion channel
10/08/2009US20090253807 Aqueous suspension preparations
10/08/2009US20090253786 Synthesis, anti-allergic, anti-asthmatic and anti-inflammatory activities of CEE-1 and CEE-2
10/08/2009US20090253767 Aminoindazolylurea derivatives
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253720 Antifolate compositions
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253678 Macrocyclic pyrimidine derivatives
10/08/2009US20090253664 Combination andolast/glucocorticoids
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009US20090252786 Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009CA2720343A1 Heterocyclic derivative and use thereof
10/07/2009EP2107110A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
10/07/2009EP2107050A1 Lipoxin compounds
10/07/2009EP2106806A1 Nanoparticles for targeted delivery of active agents to the lung
10/07/2009EP2106396A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/07/2009EP2106258A2 Non-steroid antiphlogistics against coughing
10/07/2009EP1617216B1 Novel method of screening
10/07/2009EP1529038B1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/07/2009EP1385550B1 Therapeutic medicaments for inducing tolerance
10/07/2009EP1308441B1 2-aminopyridine compounds and use thereof as drugs